Body and Mind to Acquire Northern California Cannabis Store

Body and Mind Expands in Seaside California Definitive agreements signed for acquisition of Seaside California Dispensary LAS VEGAS and VANCOUVER, BC, Dec. 1, 2021 /PRNewswire/ – Body and Mind Inc. (CSE: BAMM) (OTCQB: BMMJ)...
- December 1st, 2021 at 9:17 am

Canadian Cannabis Stocks Drop 5.5% in November

After retreating almost 27% in Q3, the Canadian Cannabis LP Index extended its losing streak to five months as it fell again in November, declining 5.5.% to 225.26: The index, which...
- December 1st, 2021 at 8:18 am

Ancillary Cannabis Index Declines 10.6% in November

Following up on our discussion earlier this year about how cannabis investors have embraced publicly traded ancillary companies, New Cannabis Ventures launched its seventh proprietary index, the Ancillary Cannabis Index, at the...
- November 30th, 2021 at 5:12 pm

The Parent Company Adds to Senior Leadership

The Parent Company Announces Tiffany McBride as Managing Director of Social Equity Ventures and Kerry Arnold as Chief People Officer Appointments Further Efforts to Build an Equitable and Inclusive...
- November 30th, 2021 at 9:17 am

IM Cannabis to Launch WAGNERS Brand in Israel

IM Cannabis Announces Focus Medical’s Receipt of Israeli Ministry of Health Import Permit; Plans to Launch WAGNERS Brand in Israel IM Cannabis’ popular recreational cannabis brand WAGNERS will be...
- November 29th, 2021 at 10:03 am

Investing in Cannabis Has Become More Nuanced

You’re reading a copy of this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight to...
- November 28th, 2021 at 10:50 am

What’s New With Cannabis Stocks for the Week Ending 11/26/21

Navigate the fast-moving cannabis sector with 420 Investor, a premium service that sends real-time alerts and explanations of the news below and much more. Summary  Germany’s leadership coalition confirmed its intent...
- November 26th, 2021 at 1:45 pm

Organigram Q4 Revenue Increases 22% to $24.9 Million

Organigram Reports Fourth Quarter Fiscal 2021 Results Continued growth in net revenue and increased market share Achieved a 7% share of market in the recreational cannabis market in Q4,...
- November 23rd, 2021 at 6:29 am